# Francis Medical

> Francis Medical is a privately held medical device company in Maple Grove, Minnesota, founded in
> 2018 by Michael Hoey and named for his father, who died of prostate cancer in 1991. It develops the
> Vanquish Water Vapor Ablation System, a transurethral outpatient platform that ablates targeted
> prostate tissue with the thermal energy stored in sterile water vapor, aiming to treat localized
> disease while avoiding the incontinence and sexual dysfunction associated with radical prostatectomy
> and radiation. Francis Medical publishes no public developer program and no machine-readable API
> contract.

Generated by the API Evangelist enrichment pipeline on 2026-08-16.
method: generated
source: apis.yml + probed public pages on www.francismedical.com

## API surface

Francis Medical has no public API. As of 2026-08-16 there is no developer portal, no API reference,
and no OpenAPI, AsyncAPI, GraphQL, MCP or A2A contract. No `api.`, `developer.`, `docs.` or `portal.`
hostname resolves on francismedical.com, and every standard discovery path on the one host that does
exist returns 404 — `/openapi.json`, `/openapi.yaml`, `/swagger.json`, `/api-docs`, `/docs`, `/redoc`,
`/graphql`, `/llms.txt`, and every `/.well-known/` path including `security.txt`, `api-catalog`,
`agent-card.json` and `agent.json`.

The company states this itself. Its Product Security page opens: "our current product offerings do not
include network-connected components." The Vanquish system is a capital device and single-use catheter
operated at the point of care, not a connected or cloud-backed platform, so there is no API surface to
document.

The only machine-readable JSON served from francismedical.com is the stock WordPress core REST API at
`/wp-json/` — namespaces `wp/v2`, `oembed/1.0`, `wp-site-health/v1`, `wp-block-editor/v1`,
`wp-abilities/v1`, plus plugin namespaces from Contact Form 7, Yoast, Wordfence, Redirection,
CookieYes, MonsterInsights, Hummingbird, WPMU DEV and Avada. That is the marketing site's CMS, not a
Francis Medical product API, and it is not listed as an API in this profile.

## Company

- [Francis Medical](https://www.francismedical.com/): Company website.
- [About](https://www.francismedical.com/about/): Company origin, founder Michael Hoey, and the water vapor platform.
- [Leadership](https://www.francismedical.com/leadership/): Executive team and board.
- [News](https://www.francismedical.com/news/): Press releases and company announcements.
- [Careers](https://www.francismedical.com/careers/): Open roles.
- [Contact](https://www.francismedical.com/contact/): Contact form and general inquiries — the published support channel.
- [LinkedIn](https://www.linkedin.com/company/francis-medical): Company profile.

## Technology and products

- [Vanquish Water Vapor Ablation System](https://www.francismedical.com/vanquish/): The clinician-facing product overview — transurethral water vapor ablation of targeted prostate tissue.
- [Vanquish for patients](https://www.francismedical.com/vanquish-patient/): Patient-facing explanation of the procedure.
- [Science](https://www.francismedical.com/science/): The mechanism of action of convective water vapor thermal energy.
- [Evidence](https://www.francismedical.com/evidence/): VAPOR 1 and VAPOR 2 clinical study data and published outcomes.
- [Education](https://www.francismedical.com/education/): Clinician education materials.
- [eIFU library](https://www.francismedical.com/emanual/): Electronic instructions for use, by product and country — PDF documents, not a machine-readable interface.
- [Physician locator](https://www.francismedical.com/physician-locator/): Find clinicians offering Vanquish. Backed by the Agile Store Locator WordPress plugin, not a published API.
- [Reimbursement](https://www.francismedical.com/reimbursement/): Coding and reimbursement guidance.
- [FAQ](https://www.francismedical.com/faq/): Common questions about the procedure.

## Regulatory and clinical status

- FDA Breakthrough Device Designation granted in August 2023.
- FDA 510(k) clearance for prostate tissue ablation announced December 2025.
- VAPOR 1 IDE study and VAPOR 2 pivotal study, plus a long-term registry, are registered on ClinicalTrials.gov (NCT04087980, NCT05683691, NCT07455058).
- Roughly $160M raised to date, including an $80M Series C in January 2025 co-led by Solas BioVentures and Arboretum Ventures.

## Security and policies

- [Product Security](https://www.francismedical.com/product-security/): Coordinated Vulnerability Disclosure policy. Reports go to product-security@francismedical.com; acknowledgement within 10 business days, updates every 30 days, and safe harbor for good-faith research. Covers device software and local operator interfaces; excludes corporate IT.
- [Privacy Policy](https://www.francismedical.com/privacy-policy/)
- [Terms and Conditions](https://www.francismedical.com/terms-and-conditions/)
- [Cookie Policy](https://www.francismedical.com/cookie-policy/)

## API Evangelist artifacts in this repository

- [security/francis-medical-vulnerability-disclosure.yml](security/francis-medical-vulnerability-disclosure.yml): The Coordinated Vulnerability Disclosure policy, captured from the provider's own page.
- [security/francis-medical-domain-security.yml](security/francis-medical-domain-security.yml): Probed TLS, HSTS, DNSSEC, CAA, SPF and DMARC posture for francismedical.com.
- [well-known/francis-medical-well-known.yml](well-known/francis-medical-well-known.yml): Recorded absence — every `/.well-known/` path probed, all 404.